Table 2.

The main clinical and demographic features of patients with interstitial pneumonia detected during “COVID” period

	n (%)
Age average ± SD (range)	66.3 ± 13.8 (18–90)
Gender F:M	89:159 (44%:56%)
Oncological disease
Lymphoma	60 (21%)
Multiple myeloma	5 (2%)
Lung	69 (24%)
Breast	36 (13%)
Gastrointestinal	18 (6%)
Head and neck	28 (10%)
Melanoma	4 (2%)
Genitourinary	22 (8%)
Other primary	42 (14%)
Indication
Staging/diagnosis	125 (44%)
Restaging/treatment response evaluation	126 (44%)
Follow-up	34 (12%)
Low lymphocyte count	38/118 (32%)
Increased ESR level	25/47 (53%)
Increased CPR level	68/94 (72%)

F, female; M, male; ESR, erythrocyte sedimentation rate; CRP, C-reactive protein